Taking Control Of Your Diabetes® - The Podcast!

Taking Control Of Your Diabetes®
  • 4.9 (130)
  • MEDICINE
  • UPDATED BIWEEKLY

Welcome to Taking Control Of Your Diabetes® - The Podcast, an edutaining show all about highs and lows of living with diabetes. Hosted by Dr. Steve Edelman and Dr. Jeremy Pettus, both endocrinologists who have been living with diabetes themselves since they were 15, we’re discussing the important topics that people living with diabetes need to know—and no topic is off-limits. From the latest advancements in diabetes medications and devices, to interviews with some of the best minds in diabetes, to personal stories about the ups and downs of dealing with this condition 24/7, we’re tackling what it means to live with diabetes in modern times. And we promise to make you laugh along the way, because sometimes we just need to laugh at the craziness that comes with living with diabetes. Tune in for a new episode on the last Monday of every month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes! VISIT: tcoyd.org | FOLLOW: tcoyd.org/contact | EMAIL: podcast@tcoyd.org APPLE PODCAST RATING: 4.9/🌟🌟🌟🌟🌟

  1. We Sat Down with Justin to Talk Diabetes Tech

    1D AGO

    We Sat Down with Justin to Talk Diabetes Tech

    Are you getting the most out of the diabetes technology you use every day and do you know what’s coming next? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with diabetes tech expert Justin Eastzer, creator of Diabetech, who is also living with type 1 diabetes, for a conversation about the steadily growing and expanding world of diabetes technology. They talk about how CGMs, automated insulin delivery systems, connected apps, and wearable displays are continuing to improve the way people with type 1 diabetes manage glucose in daily life. Justin shares his diagnosis story, including being initially treated for type 2 diabetes before learning he had type 1, and how the online diabetes community helped him find the right answers. That experience led him to build a platform dedicated to reviewing devices, following industry developments, and helping people better understand the technology available today. The discussion explores the current landscape of automated insulin delivery systems, practical differences between pumps, and the growing ecosystem of apps, displays, and data tools that allow people to interact with their glucose data in real time. They also look ahead at what’s coming next in diabetes tech, including new pump designs, smarter algorithms, improved connectivity, and continued efforts to reduce the day-to-day workload of living with type 1 diabetes. Key Topics• Why many people only use part of their diabetes tech’s capabilities• Justin’s journey to a type 1 diabetes diagnosis• Making pumps, CGMs, and apps work in everyday life• Comparing automated insulin delivery systems• Tubed vs. tubeless pump considerations• The importance of optimizing personal settings• Progress over perfection with time in range• Reducing diabetes burnout through technology• Helpful apps, displays, and tech hacks• Where diabetes technology is heading next ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    47 min
  2. T1D to 100: How to Live a Long, Healthy, and Happy Life

    FEB 24

    T1D to 100: How to Live a Long, Healthy, and Happy Life

    What does it really look like to grow older with type 1 diabetes today? The good news is people with diabetes are now living longer than ever! In this episode, Dr. Steve Edelman is joined by diabetes advocate Joanne Milo and endocrinologist Dr. Athena Tsimikas to talk about the realities of aging with type 1. They share how expectations have changed over time, why more people are now living long lives with diabetes, and what it takes to stay safe, independent, and supported through the aging process. The conversation covers changing insulin needs, screening for vision, hearing, and cognitive health, the role of technology, and the importance of community and care partners. They also discuss the emotional side of aging with diabetes, including the need to feel heard, understood, and safe while continuing to live a full and meaningful life. Key Topics• Living longer with type 1: how expectations have changed• Changing insulin sensitivity, muscle mass, and dosing over time• Preventing falls: vision, neuropathy, and mobility considerations• Cognitive health and why screening matters• Technology in older adults: CGM and hybrid closed-loop benefits• Medication considerations for heart and kidney protection• The role of care partners and support systems• Emotional health: fear, independence, and being understood• Staying active, social, and engaged while aging with diabetes• Advocacy and preparing for the future ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    37 min
  3. Travel Tips From a T1D Commercial Pilot

    FEB 12

    Travel Tips From a T1D Commercial Pilot

    What does it take to safely manage type 1 diabetes while flying a commercial jet? In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman talk with Quinton Weiskittel, a commercial pilot living with type 1 diabetes. Quinton shares what it was like to be diagnosed mid-career, how FAA rules have changed, and the real-world routines he uses to stay steady through long flights, time zones, busy airports, and long stretches of sitting. They also cover what the FAA requires for certification, how Quinton uses CGM data and smart “buffer” strategies to prevent lows, and why he’s chosen MDI over pump therapy while flying. Key Topics Being diagnosed with diabetes mid-career: the moment everything changedFAA rules on pilots with diabetes and the path back to the cockpitCGM targets, reporting requirements, and medical follow-ups as a pilot with diabetes Preventing lows during flights: alerts, trends, and planning aheadFood choices and low-carb strategies while flying a planeWhat coworkers need to know (CGM alarms, injections, and professionalism)Travel tips for diabetes: airports,travel lulls and wait time, and insulin logisticsPump therapy in the air: pressure concerns and practical tradeoffsAdvocacy and finding the right endocrinology supportLife perspective: staying grounded while chasing big goals✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    38 min
  4. How to Stop Chronic Inflammation Before It Causes Damage

    JAN 26

    How to Stop Chronic Inflammation Before It Causes Damage

    What exactly is inflammation, and how do you know if it's affecting your health? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with Dr. Jennie Luna, an endocrinologist specializing in obesity medicine and nutrition, to demystify inflammation and its connection to diabetes and metabolic health. Together, they explore the difference between acute and chronic inflammation, why chronic inflammation often goes unnoticed despite affecting nearly every organ system, and how it drives conditions like insulin resistance, fatty liver disease, and chronic kidney disease. Dr. Luna breaks down the warning signs—fatigue, brain fog, difficulty sleeping, and weight gain—and explains why these symptoms are so easy to miss. The conversation shifts to actionable strategies you can implement today. From anti-inflammatory eating patterns and time-restricted eating to managing stress and prioritizing sleep, this episode focuses on practical, realistic changes that don't require perfection or meal prep mastery. Key Topics Understanding Inflammation: The difference between acute and chronic inflammation and why chronic inflammation silently impacts metabolic health.Signs You Might Be Inflamed: Recognizing vague symptoms like fatigue, mental fog, and disrupted sleep that often go undiagnosed.Inflammation and Diabetes: How insulin resistance, high blood sugar, and inflammation create a vicious cycle—and how to break it.Anti-Inflammatory Eating Made Simple: Practical food strategies including protein-first meals, time-window eating, and budget-friendly swaps.The Fast Food Reality: Honest talk about convenience eating and how to make better choices when time is tight.Beyond Diet: Why sleep quality, stress management, and even 10-minute post-meal walks have powerful anti-inflammatory effects.GLP-1s and Inflammation: Emerging research showing these medications may reduce inflammation independent of weight loss.The Bottom Line: Why small, sustainable changes—not perfection—are the key to reducing inflammation and improving overall health.[00:00:23] - Introduction: What is inflammation? [00:00:45] - Welcome to the Taking Control of Your Diabetes Podcast [00:01:23] - Special Guest: Dr. Jennie Luna (Endocrinology & Obesity Medicine) [00:02:55] - Acute vs. Chronic Inflammation [00:03:40] - The "Stingray" Incident: A Lesson in Acute Inflammation [00:04:07] - Pro-Tip: How to do the "Stingray Shuffle" [00:05:05] - Identifying the Signs and Symptoms of Chronic Inflammation [00:07:09] - The Vicious Cycle: Inflammation and Insulin Resistance [00:08:13] - Metabolic Syndrome: Heart, Liver, and Kidney Health [00:09:24] - Why Weight Loss is the Ultimate Anti-Inflammatory [00:10:41] - Silent Triggers: Stress, Lack of Sleep, and Diet [00:12:33] - High-Yield Diet Tips: The "Protein First" Rule [00:13:28] - Time-Window Eating and Intermittent Fasting [00:15:29] - Is Healthy Eating Actually More Expensive? [00:17:25] - Realistic Habit Changes and Success Markers [00:19:53] - The Great Egg Debate: Protein vs. Cholesterol [00:21:58] - Practical Tips: Meal Prep and Chia Seed Pudding [00:25:35] - The Anti-Inflammatory Future: GLP-1s and New Research [00:27:34] - Stress Management and the Dopamine "Reward Circuit" [00:29:07] - The Link Between Sleep Apnea and Inflammation [00:30:07] - Sleep Hygiene: Removing Blue Light and Doom Scrolling [00:31:38] - The Power of Exercise and the 10-Minute Post-Meal Walk [00:32:17] - Conclusion and Final Takeaways ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    33 min
  5. 2026 Diabetes Predictions: Retatrutide, Oral GLP-1s, Stem Cell Breakthroughs… and more!

    JAN 12

    2026 Diabetes Predictions: Retatrutide, Oral GLP-1s, Stem Cell Breakthroughs… and more!

    What new advancements are actually coming in diabetes care in 2026 and what’s in store in the near future? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus both take a look at the diabetes treatments and technologies they believe are most likely to arrive in 2026. Together, they walk through emerging therapies for both type 1 and type 2 diabetes, focusing on developments that are no longer theoretical but actively moving through late-stage trials and regulatory review. The conversation covers disease-modifying treatments, next-generation medications, and technology advances that could meaningfully change daily diabetes management. Key Topics:  • Disease-Modifying Therapies for T1D: Preserving beta cell function after T1D diagnosis and why this represents a major shift in treatment goals.• New Medications for Type 2 Diabetes: Oral GLP-1s, dual- and triple-agonist therapies, and what they may offer beyond current options.• GLP-1s in Type 1 Diabetes: Where the research stands, off-label use today, and what future approvals could look like.• Once-Weekly Basal Insulin: Why it’s promising for type 2 diabetes and who it’s best suited for.• Inhaled Insulin Updates: New dosing guidance and expanded use cases.• Continuous Ketone Monitoring: How this technology could improve safety and open doors for additional therapies in T1D.• Cure-Oriented Research: Stem cell and gene therapy approaches that aim to restore insulin production.• The Big Picture in 2026: Why 2026 represents real momentum — and what it could mean for access, outcomes, and quality of life.We also created an article on this topic - READ IT HERE! ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoyd Facebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    39 min
  6. SGLT Inhibitors & What’s Next for Type 1 Diabetes: FDA’s Sotagliflozin Denial – with Stacey Simms

    12/22/2025

    SGLT Inhibitors & What’s Next for Type 1 Diabetes: FDA’s Sotagliflozin Denial – with Stacey Simms

    Why did the FDA deny sotagliflozin —even with strong data showing heart, kidney, and glucose benefits? In this episode, Dr. Steve Edelman sits down with special guest Stacey Simms to break down the full story behind SGLT inhibitors and their complicated path in type 1 diabetes. Together, they walk through how SGLT inhibitors transformed type 2 diabetes care, why many clinicians believe people with type 1 should have access, and how the risk of DKA shaped the FDA’s decision. Dr. Edelman also shares insights on who might benefit, how to reduce risk, and why continuous ketone monitoring could be a game-changer for future approvals. They also touch on the growing discussion around GLP-1 medications in type 1 diabetes, new study results, and what emerging evidence could mean for future treatment options. In this episode:  • Sotagliflozin & SGLT Inhibitors in T1D: Why these medications matter and what the latest data shows.• The FDA Denial: Understanding the DKA concerns and why approval remains challenging.• Real-World Experience: How clinicians are using SGLT inhibitors safely today in select patients.• Continuous Ketone Monitoring: Why dual-analyte sensors could unlock safer use in T1D.• GLP-1s in Type 1 Diabetes: What recent research reveals about potential benefits.• Who Might Benefit Most: Kidney protection, heart health, and metabolic improvements.• Looking Ahead: How ongoing studies and patient advocacy could shape future guidelines Learn more about Diabetes Connections with Stacey Simms: diabetes-connections.com ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoyd Facebook:   / tcoyd Stay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    30 min
  7. Dexcom G7 Sensor, The 15-Day Sensor, and What to Expect from G8 with CEO Jake Leach

    12/08/2025

    Dexcom G7 Sensor, The 15-Day Sensor, and What to Expect from G8 with CEO Jake Leach

    Continuous glucose monitoring didn’t start as sleek apps and tiny sensors — it began with chunky receivers, short wear times, and a lot of skepticism. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman sit down with Dexcom CEO and original sensor engineer Jake Leach to trace the evolution of CGM from those early “Tylenol-shaped” receivers and repurposed pagers to today’s G7 system and beyond. They walk through the major turning points: abandoning long-term implants for subcutaneous sensors, proving that real-time CGM meaningfully improves time in range and safety, and pushing back against old-school thinking that insisted patients shouldn’t see their own data. From STS 3-Day to Seven Plus, G4, G5, G6, and now G7, Dr. Edelman, Dr. Pettus, and Jake Leach break down what each generation added — better accuracy, easier insertion, smartphone and cloud connectivity, and integration with pumps and AID systems. Most importantly, Dr. Edelman, Dr. Pettus, and Dexcom CEO Jake Leach, focus on what’s coming next and what it means for people living with diabetes today: the 15 day Dexcom G7 sensor, Smart Basal insulin titration for people with type 2 diabetes, AI-powered food logging, and the upcoming G8 platform designed to measure multiple analytes (glucose plus ketones and more) — all while pushing toward broader access and affordability. Key Topics: Early Dexcom Days & STS 3-Day: How Dexcom pivoted from implantable sensors to disposable subcutaneous CGMs and what the earliest systems were really like.Blinded vs Real-Time CGM: The ethics debate, safety implications, and studies proving real-time data improves time in range and reduces hypoglycemia.Seven Plus, G4 & G5: Major accuracy improvements, longer wear times, and the move to smartphone-based monitoring.G6 & Auto-Applicators: Eliminating mandatory calibrations and making sensor insertion faster and easier.G7 Wins & Growing Pains: Reduced size, faster warm-up, early reliability challenges, and how Dexcom addressed manufacturing and support issues.15-Day Wear & Smart Basal: Extended wear life and CGM-guided basal insulin titration for type 2 diabetes.G8 & Multi-Analyte Sensing: A preview of Dexcom’s next-generation platform measuring glucose plus ketones and other markers.AI Food Logging & Smarter Care: Photo-based meal tracking and pairing nutrition data with glucose trends.Access & Affordability: Expanding CGM access globally and using data to reshape how diabetes care is delivered.0:23 - Introduction & TCOYD’s 30th Anniversary 1:39 - Meet Jake Leach: 21 Years at Dexcom 3:08 - The Early Days: From Implantable Sensors to Patches 5:26 - The First Commercial CGM (STS 3-Day) & The "Pager" Receiver 8:35 - The Evolution to 7-Day Wear (Seven Plus) 10:15 - The Early Struggles with Insurance Coverage 12:32 - Why Unblinded Real-Time Data Changed Everything 16:36 - The G4 Era: Improved Accuracy & The "Share" Cradle 20:26 - G5: The Shift to Smartphone Connectivity 27:04 - Real Talk: Addressing G7 Connectivity & Sensor Failures 29:07 - Dexcom's "Unlimited Replacement" Policy for Failed Sensors 31:39 - CONFIRMED: The New 15-Day Sensor Launch 32:43 - "Smart Basal": A New Tool for Type 2 Diabetes 35:44 - G8 Reveal: Measuring Ketones, Lactate & Potassium 39:12 - New Feature: AI Smart Food Logging 41:22 - The Future of CGM: Pre-Diabetes & Heart Health 46:34 - Closing Thoughts ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoyd  Facebook:   / tcoyd   Stay connected! Sign up for our monthly newsletter here! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

    48 min
  8. Inhaled Insulin (Afrezza) vs. Injections: Is It Actually Faster?

    11/24/2025

    Inhaled Insulin (Afrezza) vs. Injections: Is It Actually Faster?

    Get a practical breakdown of Afrezza, the ultra-rapid inhaled insulin, with this comprehensive guide to efficacy, timing, and real-world application. Join Drs. Jeremy Pettus and Steve Edelman—endocrinologists living with Type 1 diabetes—as they reveal why this unique tool is often misunderstood and how to use it effectively to flatten post-meal spikes. In this episode, we move beyond the basics to correct the biggest mistake users make regarding Afrezza dosage. If you’ve tried this therapy before and felt it "didn't work," the issue often lies in the conversion ratio. We review data from Afrezza MannKind studies (such as INHALE-3) to explain the shift from the old 1:1 ratio to the more effective 1:3 ratio. We also cover why this "rapid-on, rapid-off" insulin is the ultimate solution for exercise and how to navigate insurance coverage and prior authorizations. Topics covered in this episode: The Dosing Fix: Why you often need a higher Afrezza dosage compared to subcutaneous insulin.Speed & Kinetics: How inhaled insulin mimics the body's natural beta cells to clear glucose fast.Lifestyle Benefits: Managing "sticky highs," exercise without crashing, and dietary freedom.Safety & Screening: Spirometry requirements and who should (and shouldn't) use Afrezza.Pediatric Updates: The latest on clinical trials and potential approval for children.Whether you are managing Type 1 or Type 2 diabetes, this episode provides the practical "tips and tricks" you need to determine if Afrezza is the missing tool in your diabetes management kitTimecodes:  0:00 Start 0:24 Intro: What is Afrezza? 1:39 "Rapid On, Rapid Off" vs. Injectable Insulin 2:44 Preventing Delayed Hypoglycemia (Lows) 4:03 The Early Dosing Mistake (The 1:1 Ratio) 4:35 Jeremy’s Story: Why He Quit Using It Initially 5:44 The Correct Dosing Conversion (1:2 to 1:3) 8:09 Timing: Do You Need to Pre-Bolus? 9:16 "Follow-On" Doses for High Protein/Fat Meals 11:00 Cartridge Sizes & "Bucket" Dosing Strategy 13:10 Using Inhaled Insulin for Exercise 14:23 Real-World Test: Trix Cereal & Afrezza 15:28 Storage Tips: Fridge vs. Room Temp 16:44 Managing the Cough Side Effect 17:29 Proper Inhalation Technique 19:37 Using Afrezza with Insulin Pumps (Hybrid Closed Loop) 21:54 Pediatric Update: Is it Safe for Kids? 23:11 Why You Must Use a CGM 23:49 Lung Safety, Smokers & Spirometry Tests 24:49 How to Get It Prescribed (Overcoming Doctor Resistance) 26:27 Utilizing Trainers & Prescription Combos 29:08 Conclusion Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org **Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook  |  Instagram  |  YouTube ★ Support this podcast ★

    30 min
See All (95)

4.9
out of 5
130 Ratings

About

Welcome to Taking Control Of Your Diabetes® - The Podcast, an edutaining show all about highs and lows of living with diabetes. Hosted by Dr. Steve Edelman and Dr. Jeremy Pettus, both endocrinologists who have been living with diabetes themselves since they were 15, we’re discussing the important topics that people living with diabetes need to know—and no topic is off-limits. From the latest advancements in diabetes medications and devices, to interviews with some of the best minds in diabetes, to personal stories about the ups and downs of dealing with this condition 24/7, we’re tackling what it means to live with diabetes in modern times. And we promise to make you laugh along the way, because sometimes we just need to laugh at the craziness that comes with living with diabetes. Tune in for a new episode on the last Monday of every month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes! VISIT: tcoyd.org | FOLLOW: tcoyd.org/contact | EMAIL: podcast@tcoyd.org APPLE PODCAST RATING: 4.9/🌟🌟🌟🌟🌟

Information

You Might Also Like